|
WO2000037640A2
(en)
|
1998-12-22 |
2000-06-29 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor
|
|
KR100202640B1
(ko)
*
|
1995-12-07 |
1999-06-15 |
구본준 |
씨알티의 잔류자속 제거방법
|
|
US5712127A
(en)
|
1996-04-29 |
1998-01-27 |
Genescape Inc. |
Subtractive amplification
|
|
US6617434B1
(en)
|
1996-05-31 |
2003-09-09 |
North Shore Long Island Jewish Research Institute |
Identificiaton of differentially methylated and mutated nucleic acids
|
|
US5871917A
(en)
*
|
1996-05-31 |
1999-02-16 |
North Shore University Hospital Research Corp. |
Identification of differentially methylated and mutated nucleic acids
|
|
US5968782A
(en)
|
1996-12-04 |
1999-10-19 |
Brigham And Womens's Hospital, Inc. |
Mast cell protease that cleaves fibrinogen
|
|
US6479274B1
(en)
*
|
1997-02-13 |
2002-11-12 |
Amrad Operations Pty., Ltd. |
DNA molecules encoding human HELA2 or testisin serine proteinases
|
|
WO2001036440A1
(en)
|
1999-11-19 |
2001-05-25 |
Human Genome Sciences, Inc. |
23 human secreted proteins
|
|
US7368531B2
(en)
|
1997-03-07 |
2008-05-06 |
Human Genome Sciences, Inc. |
Human secreted proteins
|
|
US7193048B2
(en)
|
1997-03-31 |
2007-03-20 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US5981830A
(en)
*
|
1997-05-30 |
1999-11-09 |
Schering Aktiengesellschaft |
Knockout mice and their progeny with a disrupted hepsin gene
|
|
NZ503343A
(en)
|
1997-09-17 |
2002-09-27 |
Genentech Inc |
Secreted and transmembrane polypeptides and use to induce apoptosis of tumour cells
|
|
US20030092002A1
(en)
*
|
1997-09-17 |
2003-05-15 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20020192659A1
(en)
*
|
1997-09-17 |
2002-12-19 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6203979B1
(en)
*
|
1998-01-16 |
2001-03-20 |
Incyte Pharmaceuticals, Inc. |
Human protease molecules
|
|
US7022821B1
(en)
|
1998-02-20 |
2006-04-04 |
O'brien Timothy J |
Antibody kit for the detection of TADG-15 protein
|
|
WO1999057144A2
(en)
|
1998-05-05 |
1999-11-11 |
Incyte Pharmaceuticals, Inc. |
Human transcriptional regulator molecules
|
|
US6998260B1
(en)
|
1998-05-15 |
2006-02-14 |
Promega Corporation |
Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same
|
|
WO2000029448A2
(en)
|
1998-11-17 |
2000-05-25 |
Sagami Chemical Research Center |
Human proteins having hydrophobic domains and dnas encoding these proteins
|
|
US20050053983A1
(en)
*
|
1998-11-20 |
2005-03-10 |
Fuso Pharmaceutical Industries, Ltd. |
Novel serine protease BSSP4
|
|
EP1132477A4
(en)
|
1998-11-20 |
2003-05-07 |
Fuso Pharmaceutical Ind |
SERINE PROTEASE BSSP4
|
|
EP1161266A4
(en)
|
1999-03-12 |
2007-09-19 |
Univ Georgetown |
Matriptase, a serine protease and its applications
|
|
WO2001023547A1
(en)
|
1999-09-27 |
2001-04-05 |
Human Genome Sciences, Inc. |
26 human secreted proteins
|
|
US20070048818A1
(en)
|
1999-03-12 |
2007-03-01 |
Human Genome Sciences, Inc. |
Human secreted proteins
|
|
US7368527B2
(en)
|
1999-03-12 |
2008-05-06 |
Human Genome Sciences, Inc. |
HADDE71 polypeptides
|
|
US6485957B1
(en)
*
|
1999-04-30 |
2002-11-26 |
Ortho-Mcneil Pharmaceutical, Inc. |
DNA encoding the human serine protease EOS
|
|
US6420157B1
(en)
*
|
1999-04-30 |
2002-07-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Zymogen activation system
|
|
CA2379925A1
(en)
*
|
1999-07-20 |
2001-01-25 |
Curagen Corporation |
Polypeptides and polynucleotides encoding same
|
|
US20030207348A1
(en)
*
|
1999-07-20 |
2003-11-06 |
Shimkets Richard A. |
Polypeptides and polynucleotides encoding same
|
|
CA2379652A1
(en)
|
1999-08-18 |
2001-02-22 |
Zymogenetics, Inc. |
Tryptase-like polypeptide ztryp1
|
|
US6514741B1
(en)
*
|
1999-08-18 |
2003-02-04 |
Zymogenetics, Inc. |
Tryptase-like polypeptide ztryp1
|
|
US6426199B1
(en)
*
|
1999-08-31 |
2002-07-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
Dna
|
|
US6458564B1
(en)
*
|
1999-08-31 |
2002-10-01 |
Ortho-Mcneil Pharmaceutical, Inc. |
DNA encoding the human serine protease T
|
|
EP1087230A1
(en)
*
|
1999-09-24 |
2001-03-28 |
Boehringer Ingelheim International GmbH |
Method for identifying compounds useful in the therapy of bone disorders
|
|
US20060084054A1
(en)
|
1999-09-27 |
2006-04-20 |
John Alsobrook |
Novel proteins and nucleic acids encoding same
|
|
US7030231B1
(en)
|
1999-09-30 |
2006-04-18 |
Catalyst Biosciences, Inc. |
Membrane type serine protease 1 (MT-SP1) and uses thereof
|
|
AU1205901A
(en)
*
|
1999-10-14 |
2001-04-23 |
Board Of Trustees Of The University Of Arkansas, The |
Tumor antigen derived gene-16 (tadg-16): a novel extracellular serine protease and uses thereof
|
|
WO2001036645A2
(en)
|
1999-11-17 |
2001-05-25 |
Curagen Corporation |
Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
|
|
WO2001046443A2
(en)
|
1999-12-23 |
2001-06-28 |
Incyte Genomics, Inc. |
Proteases
|
|
US20030050231A1
(en)
|
2000-01-31 |
2003-03-13 |
Rosen Craig A. |
Nucleic acids, proteins, and antibodies
|
|
US20020042386A1
(en)
|
2000-01-31 |
2002-04-11 |
Rosen Craig A. |
Nucleic acids, proteins, and antibodies
|
|
US7700341B2
(en)
|
2000-02-03 |
2010-04-20 |
Dendreon Corporation |
Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
|
|
US20040043930A1
(en)
*
|
2000-02-08 |
2004-03-04 |
Anderson David W. |
Novel proteins and nucleic acids encoding same
|
|
EP1255833A2
(en)
|
2000-02-15 |
2002-11-13 |
Curagen Corporation |
Polypeptides and nucleic acids encoding same
|
|
WO2001066747A2
(en)
|
2000-03-03 |
2001-09-13 |
Curagen Corporation |
Proteins named fctrx and nucleic acids encoding same
|
|
US20030065140A1
(en)
|
2000-04-03 |
2003-04-03 |
Vernet Corine A.M. |
Novel proteins and nucleic acids encoding same
|
|
AU2001274888A1
(en)
|
2000-05-19 |
2001-12-03 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
AU2001283872A1
(en)
*
|
2000-06-21 |
2002-01-02 |
Bayer Aktiengesellschaft |
Regulation of human eosinophil serine protease 1-like enzyme
|
|
US7049420B2
(en)
*
|
2000-06-23 |
2006-05-23 |
Bayer Healthcare Ag |
Regulation of human prostasin-like serine protease
|
|
WO2001098467A2
(en)
|
2000-06-23 |
2001-12-27 |
Bayer Aktiengesellschaft |
Regulation of human prostasin-like serine protease
|
|
AU2001271427A1
(en)
*
|
2000-06-26 |
2002-01-08 |
Sugen, Inc. |
Novel proteases
|
|
US20030077647A1
(en)
*
|
2001-10-09 |
2003-04-24 |
Millennium Pharmaceuticals, Inc. |
14081, a human trypsin-like serine protease family member and uses therefor
|
|
US20020045230A1
(en)
|
2000-08-14 |
2002-04-18 |
Rosen Craig A. |
Nucleic acids, proteins, and antibodies
|
|
JPWO2002027502A1
(ja)
*
|
2000-09-26 |
2004-02-05 |
株式会社東芝 |
電子メールの送受信プログラムを記録した記録媒体
|
|
AU2002241570A1
(en)
|
2000-10-24 |
2002-06-18 |
Curagen Corporation |
Human proteins, polynucleotides encoding them and methods of using the same
|
|
WO2002059315A2
(en)
|
2000-12-19 |
2002-08-01 |
Curagen Corporation |
Human nucleic acids and polypeptides and methods of use thereof
|
|
WO2002055704A2
(en)
|
2001-01-09 |
2002-07-18 |
Curagen Corp |
Proteins, polynucleotides encoding them and methods of using the same
|
|
WO2002068647A2
(en)
|
2001-01-16 |
2002-09-06 |
Curagen Corporation |
Proteins, polynucleotides encoding them and methods of using the same
|
|
WO2002098917A2
(en)
|
2001-02-12 |
2002-12-12 |
Curagen Corporation |
Human proteins and nucleic acids encoding same
|
|
CA2438433A1
(en)
|
2001-02-14 |
2002-08-22 |
Tularik Inc. |
Methods for the diagnosis and treatment of tumors employing the hepsin gene
|
|
US6482630B2
(en)
*
|
2001-03-29 |
2002-11-19 |
Applera Corporation |
Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
|
|
US20060188903A1
(en)
*
|
2001-04-06 |
2006-08-24 |
Rancourt Derrick E |
Implantation serine proteinases
|
|
JP2004535169A
(ja)
|
2001-04-06 |
2004-11-25 |
ランコート，デリック，イー． |
着床セリンプロテアーゼ
|
|
WO2002095007A2
(en)
|
2001-05-23 |
2002-11-28 |
Dendreon San Diego Llc |
Conjugates activated by cell surface proteases and therapeutic uses thereof
|
|
AU2002324451A1
(en)
|
2001-06-21 |
2003-01-08 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
|
|
AU2002337657A1
(en)
|
2001-07-25 |
2003-02-17 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
|
|
AU2002324700A1
(en)
|
2001-08-14 |
2003-03-03 |
Bayer Ag |
Nucleic acid and amino acid sequences involved in pain
|
|
WO2003063688A2
(en)
|
2002-01-25 |
2003-08-07 |
Incyte Corporation |
Protein modification and maintenance molecules
|
|
US20040126777A1
(en)
*
|
2002-01-28 |
2004-07-01 |
Bhatt Ramesh Rajani |
Lp mammalian proteins; related reagents
|
|
EP1471818A4
(en)
|
2002-02-04 |
2007-03-28 |
Millennium Pharm Inc |
METHOD AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISEASES USING 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137 , 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 OR 13249 MOLECULES
|
|
JP2003334094A
(ja)
*
|
2002-03-15 |
2003-11-25 |
Sankyo Co Ltd |
骨代謝異常の治療または予防剤の試験方法
|
|
US7160994B2
(en)
*
|
2002-03-28 |
2007-01-09 |
Trustees Of The University Of Pennsylvania |
Osteoclast-specific genes and proteins and uses thereof
|
|
EP1792912A3
(en)
|
2002-04-02 |
2007-08-29 |
Curagen Corporation |
Novel proteins and nucleic acids encoding same
|
|
US20040001801A1
(en)
*
|
2002-05-23 |
2004-01-01 |
Corvas International, Inc. |
Conjugates activated by cell surface proteases and therapeutic uses thereof
|
|
US20030124706A1
(en)
*
|
2002-06-21 |
2003-07-03 |
Junming Yang |
Proteases
|
|
WO2004009803A2
(en)
|
2002-07-23 |
2004-01-29 |
Bayer Healthcare Ag |
Regulation of human hepsin
|
|
US6977170B2
(en)
*
|
2002-09-06 |
2005-12-20 |
Applera Corporation |
Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof
|
|
WO2004023973A2
(en)
|
2002-09-12 |
2004-03-25 |
Incyte Corporation |
Molecules for diagnostics and therapeutics
|
|
WO2004028479A2
(en)
*
|
2002-09-25 |
2004-04-08 |
Genentech, Inc. |
Nouvelles compositions et methodes de traitement du psoriasis
|
|
CA2500687A1
(en)
*
|
2002-10-02 |
2004-04-15 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
JP2006507813A
(ja)
|
2002-10-04 |
2006-03-09 |
シエーリング アクチエンゲゼルシャフト |
置換体活性化配列を有する修飾されたヘプシン分子及びその使用
|
|
AU2003279829A1
(en)
|
2002-10-04 |
2004-05-04 |
Incyte Corp |
Protein modification and maintenance molecules
|
|
AU2002951912A0
(en)
|
2002-10-08 |
2002-10-24 |
Unisearch Limited |
Tryptase polypeptide and uses thereof
|
|
AU2003295511A1
(en)
|
2002-11-13 |
2004-06-03 |
Genentech, Inc. |
Methods and compositions for diagnosing dysplasia
|
|
AU2003298786A1
(en)
|
2002-11-26 |
2004-06-18 |
Protein Design Labs, Inc. |
Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
|
|
WO2004053068A2
(en)
|
2002-12-05 |
2004-06-24 |
Incyte Corporation |
Protein modification and maintenance molecules
|
|
EP2474630B1
(en)
*
|
2002-12-20 |
2016-04-27 |
Celera Corporation |
Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
|
|
US20050181375A1
(en)
|
2003-01-10 |
2005-08-18 |
Natasha Aziz |
Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
|
|
WO2004076639A2
(en)
*
|
2003-02-26 |
2004-09-10 |
Wyeth |
Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus
|
|
WO2004086035A1
(en)
|
2003-03-28 |
2004-10-07 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with hepsin (hpn)
|
|
US20050255114A1
(en)
*
|
2003-04-07 |
2005-11-17 |
Nuvelo, Inc. |
Methods and diagnosis for the treatment of preeclampsia
|
|
WO2004093804A2
(en)
|
2003-04-18 |
2004-11-04 |
Five Prime Therapeutics, Inc. |
Human polypeptides encoded by polynucleotides and methods of their use
|
|
EP1633850A4
(en)
|
2003-05-16 |
2007-04-04 |
Diadexus Inc |
OVR115 ANTIBODY COMPOSITIONS AND METHODS OF USE
|
|
WO2004106536A2
(en)
|
2003-05-28 |
2004-12-09 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with serine protease 8 (prss8)
|
|
CN1833020A
(zh)
|
2003-06-27 |
2006-09-13 |
迪亚德克瑟斯公司 |
Pro104抗体组合物及其使用方法
|
|
WO2005005647A2
(en)
|
2003-06-30 |
2005-01-20 |
Diadexus, Inc. |
Compositions, splice variants and methods relating to ovarian specific genes and proteins
|
|
US20040137623A1
(en)
*
|
2003-09-17 |
2004-07-15 |
Isis Pharmaceuticals, Inc. |
Delivery of oligonucleotide compounds into osteoclasts and modulation of osteoclast differentiation
|
|
US20050176030A1
(en)
*
|
2003-10-28 |
2005-08-11 |
Li Gan |
Regulated nucleic acids in pathogenesis of Alzheimer's Disease
|
|
EP1711622A2
(en)
*
|
2003-11-26 |
2006-10-18 |
Applera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
|
US20050153333A1
(en)
*
|
2003-12-02 |
2005-07-14 |
Sooknanan Roy R. |
Selective terminal tagging of nucleic acids
|
|
EP1774046A4
(en)
|
2004-01-27 |
2010-09-15 |
Compugen Usa Inc |
NEW NUCLEOTIDE AND AMINO ACID SEQUENCES AND ASSAYS AND METHOD FOR THEIR USE IN THE DIAGNOSIS OF LUNG CANCER
|
|
US7569662B2
(en)
|
2004-01-27 |
2009-08-04 |
Compugen Ltd |
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
|
|
EP1713929A2
(en)
|
2004-02-03 |
2006-10-25 |
Bayer HealthCare AG |
Diagnostics and therapeutics for diseases associated with plasma kallikrein (klkb1)
|
|
US20060084066A1
(en)
*
|
2004-02-20 |
2006-04-20 |
Sah Dinah W Y |
Surrogate markers of neuropathic pain
|
|
WO2005119262A2
(en)
|
2004-05-27 |
2005-12-15 |
Galapagos N.V. |
Methods, compositions and compound assays for inhibiting amyloid-beta protein production
|
|
KR101222254B1
(ko)
|
2004-07-26 |
2013-01-16 |
제넨테크, 인크. |
간세포 성장 인자 활성화를 조정하기 위한 조성물 및 방법
|
|
WO2006013016A2
(en)
|
2004-08-04 |
2006-02-09 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with eosinophil serine protease 1 (prss21)
|
|
WO2006013015A2
(en)
|
2004-08-04 |
2006-02-09 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with marapsin (mpn)
|
|
US7622265B2
(en)
|
2005-02-22 |
2009-11-24 |
Genentech, Inc. |
Methods and compositions for modulating prostasin
|
|
WO2007047796A2
(en)
|
2005-10-17 |
2007-04-26 |
Institute For Systems Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
|
KR101126423B1
(ko)
*
|
2005-10-21 |
2012-07-11 |
카탈리스트 바이오사이언시즈, 인코포레이티드 |
보체 활성화를 억제하는 변형된 프로테아제
|
|
US7510850B2
(en)
|
2005-11-10 |
2009-03-31 |
Carnegie Institution Of Washington |
Isolation of the mitotic spindle matrix and its methods of use
|
|
EP1963534A2
(en)
|
2005-12-19 |
2008-09-03 |
Genizon Biosciences Inc. |
Genemap of the human gene associated with crohn's disease
|
|
WO2007140907A1
(en)
|
2006-06-07 |
2007-12-13 |
Bayer Healthcare Ag |
Use of serine endopeptidases 22 (prss22) as a therapeutic or diagnostic target
|
|
CN101490088B
(zh)
|
2006-06-22 |
2015-04-08 |
健泰科生物技术公司 |
用于靶向hepsin的方法和组合物
|
|
US20100061996A1
(en)
|
2006-06-22 |
2010-03-11 |
Genentech, Inc. |
Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator
|
|
EP2052088A2
(en)
*
|
2006-08-02 |
2009-04-29 |
Genizon Biosciences |
Genemap of the human genes associated with psoriasis
|
|
CA2660286A1
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
CA2670107A1
(en)
*
|
2006-11-22 |
2008-06-05 |
The Board Of Trustees Of The University Of Arkansas |
Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer
|